Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Lipid Profiles and Safety of Raltegravir Based Antiretroviral Therapy in HIV-1-infected Patients With Hyperlipidemia While on Current Standard Therapy

NCT00887653 is registered in ClinicalTrials.gov with The Miriam Hospital as lead sponsor.

NCT NCT00887653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00887653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Lipid Profiles and Safety of Raltegravir Based Antiretroviral Therapy in HIV-1-infected Patients With Hyperlipidemia While on Current Standard Therapy
Lead sponsor
The Miriam Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2009
Completion date
April 30, 2014
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, hiv infections, hyperlipidemia, hypertriglyceridemia